Literature DB >> 11185552

Physicochemical evaluation of a stability-driven approach to drug entrapment in regular and in surface-modified liposomes.

D Peer1, R Margalit.   

Abstract

The traditional mode of encapsulating drugs in liposomes poses risks to drug stability, especially when recognition agents are attached to the liposomal surface to obtain targeted liposomes. To reduce such risks, we devised a simple, novel method to entrap drugs in liposomes, consisting of (i) preparation and lyophilization of drug-free regular and surface-modified liposomes and (ii) drug encapsulation in the course of liposome reconstitution through rehydration in an aqueous solution of the drug. In this paper, we report physicochemical studies in which we compared regular and surface-modified liposomes made by this novel approach (denoted N-liposomes) to respective liposomes made by the traditional mode (denoted T-liposomes). The studies were performed with fluorescein, sucrose, histidine, mitomycin C (MMC), and chloramphenicol (CAM) encapsulated (each) in regular and in bioadhesive liposomes, the latter having hyaluronic acid as the surface-bound ligand. Our major findings are as follows: (1) The drug-specific encapsulation efficiencies spanning the range of 10-90% were, excepting sucrose, either similar in the N- and T-liposomes or better in the N- than in the T-liposomes, for both regular and bioadhesive liposomes. (2) For all liposome types and methods of preparation, fluorescein, histidine, and MMC did not adsorb to the liposomal surface. Sucrose and MMC did adsorb to the liposomal surface irrespective of the liposome preparation mode, sucrose favoring bioadhesive over regular liposomes and MMC having the opposite trend. (3) For both regular and bioadhesive liposomes, the mechanism of drug efflux from the N-liposomes was found to be governed by a single rate constant, as previously found for the T-liposomes. The magnitudes obtained, ranging from 3.5(+/-0.2) x 10(-3) to 400(+/-17) x 10(-3) h(-1), were always drug specific and occasionally also liposome type (i.e., regular or bioadhesive) specific. For MMC and CAM, the novel approach rendered liposomes with improved sustained release. The results reported here attest, overall, to the potential of this novel approach, meriting further investigations. Studies currently underway with MMC indicate N-liposomes also have functional advantages.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11185552     DOI: 10.1006/abbi.2000.2046

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  6 in total

Review 1.  Hyaluronan-CD44 interactions as potential targets for cancer therapy.

Authors:  Suniti Misra; Paraskevi Heldin; Vincent C Hascall; Nikos K Karamanos; Spyros S Skandalis; Roger R Markwald; Shibnath Ghatak
Journal:  FEBS J       Date:  2011-03-25       Impact factor: 5.542

2.  RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice.

Authors:  Sang-Soo Kim; Dan Peer; Priti Kumar; Sandesh Subramanya; Huaquan Wu; Deshratan Asthana; Katsuyoshi Habiro; Yong-Guang Yang; N Manjunath; Motomu Shimaoka; Premlata Shankar
Journal:  Mol Ther       Date:  2009-12-08       Impact factor: 11.454

3.  Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal Doxorubicin in syngeneic and human xenograft mouse tumor models.

Authors:  Dan Peer; Rimona Margalit
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

Review 4.  Hyaluronan and synovial joint: function, distribution and healing.

Authors:  Tamer Mahmoud Tamer
Journal:  Interdiscip Toxicol       Date:  2013-09

5.  Antibacterial and cytotoxic efficacy of extracellular silver nanoparticles biofabricated from chromium reducing novel OS4 strain of Stenotrophomonas maltophilia.

Authors:  Mohammad Oves; Mohammad Saghir Khan; Almas Zaidi; Arham S Ahmed; Faheem Ahmed; Ejaz Ahmad; Asif Sherwani; Mohammad Owais; Ameer Azam
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

6.  SATB1 siRNA-encapsulated immunoliposomes conjugated with CD44 antibodies target and eliminate gastric cancer-initiating cells.

Authors:  Feng Yang; Zhi Zheng; Luming Zheng; Jianmin Qin; Haijia Li; Xuchao Xue; Jie Gao; Guoen Fang
Journal:  Onco Targets Ther       Date:  2018-10-11       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.